Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Business Officer

President and CEO

Chief Scientific Officer

Chief Financial Officer

General Counsel

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company also develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The Company was incorporated in 2017 and is headquartered in Boulder, Colorado.

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle di...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-02	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-05-02	Premium	sold	Premium	Premium	Premium	President and CEO
2024-05-02	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-05-02	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-05-02	Premium	sold	Premium	Premium	Premium	General Counsel
2024-05-02	Premium	sold	Premium	Premium	Premium	CMO
2024-05-01	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-05-01	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-05-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-05-01	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-05-01	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-05-01	Premium	acquired	Premium	Premium	Premium	CMO
2024-02-09	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-02-09	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-02-08	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-08	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-02-08	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-02-08	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-02-07	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-07	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-02-07	Premium	sold	Premium	Premium	Premium	Chief Business Officer
2024-02-07	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-01-23	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

EWTX - Edgewise Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for EWTX